NAD Could Jog Cognitive Benefit Supplement Firm's Memory With FTC Call
This article was originally published in The Rose Sheet
NAD refers UltraMax Health's supplement claim to the FTC after it fails to provide substantiation. CRN emphasizes claims alone are not the problem, but the firm's failure to provide substantiation.
You may also be interested in...
Michigan firm likely remembered burden for substantiating health as well as structure/function claims under FDA regulations for supplements after NAD reviewed its ad materials presented online, in videos and in news releases submitted by Vision Elements.
Memory Health supplement was developed and is launching in the US after a small European study of Alzheimer’s patients finds improvement in patients taking a carotenoid/omega-3 combination, says marketer Avantius Group. A larger-scale, double blinded clinical study is underway in Europe.
Council of Better Business Bureau's industry self-regulation arm says UltraMax Health, after previously not responding to a request for evidence supporting Max Synapse online ad claims, stated in writing that it stopped using the claims and no longer is selling the product.